FLT3 Mutated AML

FLT3-mutated acute myeloid leukemia (AML) is an aggressive blood cancer with specific genetic mutations affecting FLT3 genes. Early detection and targeted therapies improve outcomes. Discover innovative treatments and clinical trials for FLT3 AML now. Consult your doctor today for personalized care and advanced solutions.